Case Report: A Patient with COVID-19 under Myelosuppression Induced by Chemotherapy

COVID-19 has now spread globally, and 10–20% of the cases are thought to proceed to a severe condition. However, information on COVID-19 in immunodeficient patients remains limited. We treated a 56-year-old man who developed COVID-19 after chemotherapy for mantle cell lymphoma. After 1 month of prol...

Descripción completa

Detalles Bibliográficos
Autores principales: Otsuka, Yuki, Kobayashi, Taiichiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society of Tropical Medicine and Hygiene 2020
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7646807/
https://www.ncbi.nlm.nih.gov/pubmed/32940203
http://dx.doi.org/10.4269/ajtmh.20-0678
_version_ 1783606852712398848
author Otsuka, Yuki
Kobayashi, Taiichiro
author_facet Otsuka, Yuki
Kobayashi, Taiichiro
author_sort Otsuka, Yuki
collection PubMed
description COVID-19 has now spread globally, and 10–20% of the cases are thought to proceed to a severe condition. However, information on COVID-19 in immunodeficient patients remains limited. We treated a 56-year-old man who developed COVID-19 after chemotherapy for mantle cell lymphoma. After 1 month of prolonged fever, the patient’s respiratory condition deteriorated rapidly, and he died. COVID-19 in immunocompromised patients after chemotherapy, even with mild symptoms, can cause rapid immune reconstitution and respiratory deterioration. Therefore, caution is advised until negative PCR test results for SARS-CoV-2 are confirmed.
format Online
Article
Text
id pubmed-7646807
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher The American Society of Tropical Medicine and Hygiene
record_format MEDLINE/PubMed
spelling pubmed-76468072020-11-17 Case Report: A Patient with COVID-19 under Myelosuppression Induced by Chemotherapy Otsuka, Yuki Kobayashi, Taiichiro Am J Trop Med Hyg Articles COVID-19 has now spread globally, and 10–20% of the cases are thought to proceed to a severe condition. However, information on COVID-19 in immunodeficient patients remains limited. We treated a 56-year-old man who developed COVID-19 after chemotherapy for mantle cell lymphoma. After 1 month of prolonged fever, the patient’s respiratory condition deteriorated rapidly, and he died. COVID-19 in immunocompromised patients after chemotherapy, even with mild symptoms, can cause rapid immune reconstitution and respiratory deterioration. Therefore, caution is advised until negative PCR test results for SARS-CoV-2 are confirmed. The American Society of Tropical Medicine and Hygiene 2020-11 2020-09-16 /pmc/articles/PMC7646807/ /pubmed/32940203 http://dx.doi.org/10.4269/ajtmh.20-0678 Text en © The American Society of Tropical Medicine and Hygiene This is an open-access article distributed under the terms of the Creative Commons Attribution (CC-BY) License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Articles
Otsuka, Yuki
Kobayashi, Taiichiro
Case Report: A Patient with COVID-19 under Myelosuppression Induced by Chemotherapy
title Case Report: A Patient with COVID-19 under Myelosuppression Induced by Chemotherapy
title_full Case Report: A Patient with COVID-19 under Myelosuppression Induced by Chemotherapy
title_fullStr Case Report: A Patient with COVID-19 under Myelosuppression Induced by Chemotherapy
title_full_unstemmed Case Report: A Patient with COVID-19 under Myelosuppression Induced by Chemotherapy
title_short Case Report: A Patient with COVID-19 under Myelosuppression Induced by Chemotherapy
title_sort case report: a patient with covid-19 under myelosuppression induced by chemotherapy
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7646807/
https://www.ncbi.nlm.nih.gov/pubmed/32940203
http://dx.doi.org/10.4269/ajtmh.20-0678
work_keys_str_mv AT otsukayuki casereportapatientwithcovid19undermyelosuppressioninducedbychemotherapy
AT kobayashitaiichiro casereportapatientwithcovid19undermyelosuppressioninducedbychemotherapy

Ejemplares similares